A systematic review and meta-analysis across 62 randomized controlled trials found no clear mortality benefit across six common sepsis treatment domains. The work reports that none of the analyzed intervention categories demonstrated consistent reductions in death, emphasizing uncertainty around which bundles reliably improve survival in heterogeneous patient populations. For critical care decision-makers, the findings strengthen the case for precision in trial design and patient stratification, rather than assuming that broadly adopted sepsis domains translate into uniform survival improvements. The meta-analysis may also influence how stakeholders interpret new sepsis protocols and how future studies choose endpoints, populations, and comparator arms.
Get the Daily Brief